What does CUSIP 23256X100 represent in this 13F holders report?

CUSIP 23256X100 is the security identifier for CYBN - CYBIN INC. - Common Shares, no par value used to aggregate holder disclosures.

How many institutions held CYBN - CYBIN INC. - Common Shares, no par value in Q1 2023?

60 institutional investors reported CYBN - CYBIN INC. - Common Shares, no par value for Q1 2023. Use the holders table for investor-level position and value details.

CYBIN INC. - Common Shares, no par value (CYBN)

CUSIP: 23256X100

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Shares, no par value
Total 13F shares: 7,323,756
Total 13F value: $2,821,544
Share change: -4,069,288
SEC-reported price per share: $0.38
Number of holders: 60
Value change: -$1,130,653
Number of buys: 22
Number of sells: 22
Shares outstanding: 49,047,786

Security key

23256X100

Report period

Q1 2023

Institutions

Top holders

CYBN full security history Ownership snapshot Full 13F holder table Helus Pharma Inc. SEC filings Helus Pharma Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYBN - CYBIN INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

31 Dec 2022

13F Highest disclosed value: $1,651,629 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $1.65M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $1.65M

MORGAN STANLEY $776.5K

AdvisorShares Investments LLC $498.6K

Belpointe Asset Management LLC $76.7K

CITADEL ADVISORS LLC $36.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$1,651,629 5,386,299 shares	—	31 Dec 2022
MORGAN STANLEY	13F Company 13F	— denominator unverified	$776,452 2,613,435 shares	—	31 Dec 2022
AdvisorShares Investments LLC	13F Company 13F	— denominator unverified	$498,632 1,678,331 shares	—	31 Dec 2022
Belpointe Asset Management LLC	13F Company 13F	— denominator unverified	$76,683 258,105 shares	—	31 Dec 2022
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$36,632 123,297 shares	—	31 Dec 2022
ROYAL BANK OF CANADA	13F Company 13F	— denominator unverified	$33,000 109,239 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,323,756

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %